DE602005016803D1 - Zusammensetzungen mit strontium und vitamin d und ihre verwendungen - Google Patents

Zusammensetzungen mit strontium und vitamin d und ihre verwendungen

Info

Publication number
DE602005016803D1
DE602005016803D1 DE602005016803T DE602005016803T DE602005016803D1 DE 602005016803 D1 DE602005016803 D1 DE 602005016803D1 DE 602005016803 T DE602005016803 T DE 602005016803T DE 602005016803 T DE602005016803 T DE 602005016803T DE 602005016803 D1 DE602005016803 D1 DE 602005016803D1
Authority
DE
Germany
Prior art keywords
strontium
vitamin
compositions
pharmaceutical composition
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602005016803T
Other languages
German (de)
English (en)
Inventor
John Nikolaj Christensen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Strontin ApS
Original Assignee
Strontin ApS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34972075&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE602005016803(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Strontin ApS filed Critical Strontin ApS
Publication of DE602005016803D1 publication Critical patent/DE602005016803D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE602005016803T 2004-06-25 2005-06-24 Zusammensetzungen mit strontium und vitamin d und ihre verwendungen Expired - Lifetime DE602005016803D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA200400991 2004-06-25
DKPA200401733 2004-11-10
PCT/DK2005/000425 WO2006000224A2 (en) 2004-06-25 2005-06-24 Compositions comprising strontium and vitamin d and uses thereof

Publications (1)

Publication Number Publication Date
DE602005016803D1 true DE602005016803D1 (de) 2009-11-05

Family

ID=34972075

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602005016803T Expired - Lifetime DE602005016803D1 (de) 2004-06-25 2005-06-24 Zusammensetzungen mit strontium und vitamin d und ihre verwendungen

Country Status (15)

Country Link
US (1) US8658206B2 (enExample)
EP (1) EP1768748B2 (enExample)
JP (2) JP5070046B2 (enExample)
KR (1) KR20070034075A (enExample)
AT (1) ATE443541T1 (enExample)
AU (1) AU2005256317B2 (enExample)
BR (1) BRPI0512357A (enExample)
CA (1) CA2571449C (enExample)
DE (1) DE602005016803D1 (enExample)
DK (1) DK1768748T4 (enExample)
EA (1) EA011814B1 (enExample)
IL (1) IL180144A0 (enExample)
MX (1) MXPA06015187A (enExample)
NO (1) NO20070206L (enExample)
WO (1) WO2006000224A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080118603A1 (en) * 2006-11-21 2008-05-22 Lada Mark W Nutritional beverage for optimal bone health
WO2008061535A1 (en) * 2006-11-21 2008-05-29 Strontin Aps Compositions comprising strontium and uses thereof in the treatment or prevention of gingivitis, periodontitis, periodontitis as a manifestation of systemic diseases, and necrotizing periodontal diseases.
ES2573327T3 (es) * 2007-04-23 2016-06-07 Baxter International Inc. Composiciones de fibrina que contienen compuestos de estroncio
WO2009010305A2 (en) * 2007-07-19 2009-01-22 Dsm Ip Assets B.V. Tablettable formulations of lipophilic health ingredients
US8790714B2 (en) 2007-08-03 2014-07-29 Nucitec, S.A. De C.V. Compositions and methods for treatment and prevention of osteoarthritis
EP2416756A2 (en) * 2009-04-10 2012-02-15 Mahmut Bilgic Stable pharmaceutical compositions with high bioavailibility
FR2945748A1 (fr) * 2009-05-20 2010-11-26 Debregeas Et Associes Pharma Medicament a base de calcium et de vitamine d.
FR2953139B1 (fr) * 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
EP2591354B1 (en) * 2010-07-07 2016-09-07 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
EP2590656B1 (en) 2010-07-07 2017-11-15 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP5827328B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
EP2590965B1 (en) 2010-07-07 2016-04-20 Ardelyx, Inc. Compounds and methods for inhibiting phosphate transport
JP5827326B2 (ja) 2010-07-07 2015-12-02 アーデリクス，インコーポレーテッド リン酸輸送を阻害する化合物及び方法
AU2012212385B2 (en) * 2011-02-02 2015-01-15 Ent Technologies Pty Ltd Compositions and methods for the treatment of nasal passages
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
WO2014044756A1 (en) * 2012-09-20 2014-03-27 Mokwalo SA Strontium as anti microbial compound

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3345265A (en) * 1963-10-09 1967-10-03 Kendall & Co Multiple layer tablet with calcium salt central core separated from soluble fluoride outer coating
US3699221A (en) * 1965-02-23 1972-10-17 Murray L Schole Dental preparations
US3988434A (en) 1972-08-07 1976-10-26 Schole Murray L Dental preparation
FR2633619B1 (fr) 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.
FR2658816A1 (fr) * 1990-02-27 1991-08-30 Adir Nouveaux sels de metaux alcalinoterreux d'oxa-polyacides leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
US5380530A (en) 1992-12-29 1995-01-10 Whitehill Oral Technologies Oral care composition coated gum
US5624906A (en) * 1994-12-08 1997-04-29 Lever Brothers Company, Division Of Conopco, Inc. Oral hygiene compositions comprising heteroatom containing alkyl aldonamide compounds
FR2749759B1 (fr) 1996-06-17 1999-11-26 Adir Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose
CN1164603C (zh) 2001-09-29 2004-09-01 南京化工大学 1，6－二磷酸果糖锶盐系列化合物及其制备方法和在医药中的应用
FR2844797B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844796A1 (fr) 2002-09-24 2004-03-26 Servier Lab Nouveau procede de synthese industrielle du diester methylique de l'acide 5-amino-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
PT1534305E (pt) 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
PT1622630E (pt) 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt

Also Published As

Publication number Publication date
KR20070034075A (ko) 2007-03-27
EP1768748A2 (en) 2007-04-04
JP2012193208A (ja) 2012-10-11
HK1102427A1 (en) 2007-11-23
JP5070046B2 (ja) 2012-11-07
DK1768748T4 (da) 2019-06-11
EA011814B1 (ru) 2009-06-30
EP1768748B2 (en) 2019-03-13
CA2571449C (en) 2015-12-08
DK1768748T3 (da) 2010-02-01
US8658206B2 (en) 2014-02-25
US20080026037A1 (en) 2008-01-31
WO2006000224A2 (en) 2006-01-05
CA2571449A1 (en) 2006-01-05
EA200700130A1 (ru) 2007-06-29
BRPI0512357A (pt) 2008-03-04
WO2006000224A3 (en) 2006-05-18
JP2008503504A (ja) 2008-02-07
NO20070206L (no) 2007-03-22
MXPA06015187A (es) 2007-09-27
EP1768748B1 (en) 2009-09-23
IL180144A0 (en) 2007-06-03
AU2005256317A1 (en) 2006-01-05
ATE443541T1 (de) 2009-10-15
AU2005256317B2 (en) 2011-09-15

Similar Documents

Publication Publication Date Title
NO20070206L (no) Sammensetninger inneholdende strontium og vitamin D og anvendelser derav
SG146657A1 (en) Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
WO2006096434A3 (en) Pharmaceutical compositions for the treatment and/or prevention of anxiety disorders
IN2012DN01233A (enExample)
TW200716584A (en) Dihydrobenzofuran derivatives and uses thereof
MY143795A (en) Tetrahydropyridoindole derivatives
ZA200806778B (en) N-Hydroxyacrylamide compounds
TW200732296A (en) Novel compounds
CR10305A (es) "derivados sustituidos de cromanol y su uso.
MX2009013501A (es) Compuestos piperidinicos y sus usos.
ECSP066883A (es) Derivados de heteroarilaminopirazol utiles para el tratamiento de la diabetes
TW200722081A (en) New therapeutic combinations for the treatment or prevention of depression
WO2008079610A3 (en) Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
TW200716204A (en) Pharmaceutical composition
TW200734334A (en) Treatment of substance abuse
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
EA201170101A1 (ru) Фармацевтические композиции роувастатина кальция
EA200702282A1 (ru) Комбинация феррохина и производного артемизинина для лечения малярии
TW200800993A (en) Organic compounds
MX2008003422A (es) Composiciones que comprenden al menos un derivado de acido naftoico y al menos un compuesto de tipo polimero de poliuretano o derivados del mismo, procesos de preparacion y composiciones que comprenden al menos un derivado de acido naftoico y al meno
GB0524814D0 (en) Compounds
DE602006010738D1 (de) Pyrroloä2,3-cüpyridinderivate
WO2006077024A3 (en) 5-aminoindole derivatives
DE602006009259D1 (de) Pharmazeutische zusammensetzung mit einem organopoirkstoff
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon

Legal Events

Date Code Title Description
8363 Opposition against the patent